• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Enfusion Announces Third Quarter 2024 Results

    11/4/24 7:30:00 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email

    Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its third quarter 2024 financial results as part of its Q3 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com.

    3Q24 Earnings Conference Call

    Management will host a conference call today, November 4, 2024, at 8:30 AM ET to discuss the results.

    To pre-register for the live teleconference of the second quarter earnings call, please use this link. To access this call, dial (888) 596-4144. The conference ID number is 9652536.

    The earnings conference call will also be webcast live. Due to high call volumes, we urge interested parties to join the live webcast of the event through Enfusion's website at https://ir.enfusion.com/events-and-presentations/events/default.aspx.

    About Enfusion

    Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents.

    Source: Enfusion, Inc.

    Source Code: ENFN-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241101527085/en/

    Get the next $ENFN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Enfusion with a new price target

      Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

      5/10/24 8:40:24 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by Goldman with a new price target

      Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

      2/28/24 6:16:11 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by JP Morgan with a new price target

      JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

      1/30/24 6:55:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    SEC Filings

    See more
    • SEC Form 15-12G filed by Enfusion Inc.

      15-12G - Enfusion, Inc. (0001868912) (Filer)

      5/1/25 4:15:29 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form EFFECT filed by Enfusion Inc.

      EFFECT - Enfusion, Inc. (0001868912) (Filer)

      4/24/25 12:15:09 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form POS AM filed by Enfusion Inc.

      POS AM - Enfusion, Inc. (0001868912) (Filer)

      4/21/25 4:57:41 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology